What is the purpose and application of the New Ballard score in assessing gestational age in newborns?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

New Ballard Score for Gestational Age Assessment

Primary Purpose and Clinical Application

The New Ballard Score (NBS) is a clinical tool that combines physical and neuromuscular maturity criteria to estimate gestational age in newborns, particularly useful when obstetric dating is unavailable or uncertain, though it has significant limitations in extremely premature infants and specific clinical scenarios. 1

Optimal Timing and Accuracy

  • The NBS should be performed within the first 48 hours of life for optimal accuracy, with validity extending through day 7 of postnatal age in moderately preterm neonates (29-35 weeks). 1, 2

  • For extremely premature infants (<26 weeks gestational age), the examination achieves greatest validity (97% within 2 weeks of confirmed gestational age) when performed before 12 hours of postnatal age. 1

  • For infants ≥26 weeks gestational age, accuracy remains constant through 96 hours of postnatal age, averaging 92% agreement within 2 weeks of confirmed gestational age. 1

Score Components and Methodology

The NBS evaluates two distinct categories:

  • Physical maturity criteria: skin texture, lanugo, plantar creases, breast tissue, eye/ear development, and genitalia. 1

  • Neuromuscular maturity criteria: posture, square window, arm recoil, popliteal angle, scarf sign, and heel-to-ear maneuver. 1

  • The correlation between individual criteria and confirmed gestational age ranges from 0.72 to 0.82, with an overall correlation of 0.97 between NBS and confirmed gestational age by last menstrual period and ultrasound. 1

Critical Limitations and Pitfalls

Extremely Premature Infants (<28 weeks)

The NBS significantly overestimates gestational age in extremely premature infants, with errors of 1.3 to 3.3 weeks at each week from 22 to 28 weeks, and confidence intervals spanning 6.8 to 11.9 weeks. 3

  • This inaccuracy is clinically significant and should be considered when making decisions about intensive care initiation or withdrawal in borderline viable infants. 3

  • The NBS does not contribute significantly to predicting death, poor outcomes, or duration of hospital stay in extremely premature populations. 3

Small-for-Gestational-Age (SGA) Neonates

  • The NBS overestimates gestational age by approximately 0.7 weeks in SGA neonates due to accelerated physical maturity parameters, particularly skin texture and plantar creases. 4

  • The neuromuscular component remains accurate, but physical parameters show falsely advanced scores in growth-restricted infants. 4

  • Adjusting skin and plantar crease scores from 4 to 3 in SGA neonates reduces overestimation to 0.4 weeks. 4

Maternal Corticosteroid Exposure

  • Prenatal corticosteroid therapy causes the NBS to overestimate gestational age by 1.2 to 2.9 weeks compared to ultrasound or last menstrual period dating. 5

  • This effect is particularly pronounced in very preterm newborns whose mothers received antenatal steroids. 5

Inter-rater Reliability

  • Inter-rater reliability is excellent, with intraclass correlation coefficients of 0.95-0.97 between different examiners. 1, 2

  • Neurological signs demonstrate higher reliability (ICC 0.97-0.98) than physical signs (ICC 0.88-0.92) across repeated assessments. 2

Clinical Decision-Making Algorithm

When NBS differs from obstetric dating by ≥2 weeks, prioritize the obstetric estimate (particularly first-trimester ultrasound with crown-rump length) over the NBS for all clinical decisions. 6

  • First-trimester ultrasound with crown-rump length measurement (8-13 weeks) provides accuracy within ±5-7 days and should always supersede NBS when available. 6

  • The NBS serves as a supplementary tool when obstetric dating is unavailable, unreliable, or when confirming appropriate fetal growth and development. 1

Specific Clinical Scenarios Requiring Caution

  • Extremely premature infants (<28 weeks): Do not use NBS as the primary basis for resuscitation decisions; rely on obstetric dating when available. 3

  • SGA neonates: Expect 0.4-0.7 week overestimation and consider adjusting interpretation accordingly. 4

  • Post-corticosteroid exposure: Anticipate 1.2-2.9 week overestimation in very preterm infants. 5

  • Discrepancies >2 weeks from obstetric dating: Investigate for growth restriction, maternal factors, or dating errors rather than accepting NBS estimate. 5, 3

Practical Application

  • The NBS remains valid for the entire newborn population from 20 to 44 weeks gestational age when used appropriately and with awareness of its limitations. 1

  • Mean differences between NBS and confirmed gestational age average 0.15 ± 1.46 weeks in the general population, but this precision deteriorates significantly at gestational age extremes. 1

  • The tool provides reasonable estimates for moderately preterm neonates (29-35 weeks) with accuracy maintained through the first week of life. 2

References

Research

Validity of New Ballard Score until 7th day of postnatal life in moderately preterm neonates.

Archives of disease in childhood. Fetal and neonatal edition, 2009

Research

[Assessment of the new Ballard score to estimate gestational age].

Anales de pediatria (Barcelona, Spain : 2003), 2006

Guideline

Determining the Due Date in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.